Prodotti farmaċewtiċi
Displaying 1 - 10 of 22
Pages
Adottati on 22/05/2013
Referenza:
INT/694-EESC-2013-3335Referral:
COM(2013) 168 final - 2012/0035 (COD)Sessjoni plenarja:
490 -
May 22, 2013 May 23, 2013
Adottati on 22/02/2012
Referenza:
INT/601-EESC-2012-468Referral:
COM(2011) 632 final - 2008/0255 (COD)Sessjoni plenarja:
478 -
Feb 22, 2012 Feb 23, 2012
Adottati on 16/10/2013
Referenza:
INT/712-EESC-2013-5169Referral:
COM(2013) 472 final - 2013/0222 (COD)Rapporteur:
Sessjoni plenarja:
493 -
Oct 16, 2013 Oct 17, 2013
Adottati on 22/02/2012
Referenza:
INT/602-EESC-2012-469Referral:
COM(2011) 633 final - 2008/0256 (COD)Sessjoni plenarja:
478 -
Feb 22, 2012 Feb 23, 2012
Adottati on 21/01/2014
Referenza:
SOC/497-EESC-2013-6166Rapporteur:
Sessjoni plenarja:
495 -
Jan 21, 2014 Jan 22, 2014
Adottati on 10/06/2009
Referenza:
INT/469-EESC-2009-1022Referral:
COM(2008) 663 final - 2008/0256 (COD)Rapporteur:
Sessjoni plenarja:
454 -
Jun 10, 2009 Jun 11, 2009
Adottati on 29/04/2014
Referenza:
CCMI/119-EESC-2013-6794Rapporteur:
Mr. Almeida Freire (Employers - GR I / Portugal)
Co-rapporteur:
Mr Gibellieri (Workers - GR II/Italy)
Due to the increased need for cost-efficient procedures and the pressure on public expenditure, the European market for pharmaceutical products is less dynamic than in the past. This high-technology sector is faced with the following challenges: austerity measures introduced by European governments, rapid growth in the market and research in emerging economies, and migration of economic, research and development activities outside of Europe.
Adottati on 10/06/2009
Referenza:
INT/475-EESC-2009-1025Referral:
COM(2008) 662 final - 2008/0255 (COD)Rapporteur:
Sessjoni plenarja:
454 -
Jun 10, 2009 Jun 11, 2009
Adottati on 23/04/2015
Referenza:
CCMI/128-EESC-0000Rapporteur:
Co-rapporteur:
Jarré Dirk (Diversity Europe - GR III/Germany)
Health and related sectors are a central aspect of human existence and thus attract particular attention of citizens. The sectors of biomedical engineering and the medical and care services industry – including research and development – are among the fastest growing industrial areas, in terms of turnover as well as employment. Under biomedical engineering we understand the bridging between methods of engineering and medicine and biology for diagnostic and therapeutic measures in healthcare – including, among others, biologics and biopharmaceuticals, pharmaceutical drugs, various types of devices for chemical or biological analysis or processing as well as the development of medical equipment and technology for cure, treatment and prevention of disease. The combination of research and development, engineering and industrial production, and medical and care services is particularly important.
Downloads: